TTRX

Turn Therapeutics Inc. TTRX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$8.48M total
SteelPeak Wealth, LLC
$1.82MNew
IEQ CAPITAL, LLC
$1.66MNew
DDFG, Inc
$787.2K+52.9%
VANGUARD CAPITAL MANAGEMENT LLC
$542.4K+50.3%
Wellington Shields & Co., LLC
$479.8K0.0%
MILLENNIUM MANAGEMENT LLC
$442.0K-13.2%
BlackRock, Inc.
$281.7KNew
Bridgewater Advisors Inc.
$241.6KNew
Aaron Wealth Advisors LLC
$237.7KNew
Tamar Securities, LLC
$219.0K0.0%
ROYAL BANK OF CANADA
$206.0KNew
CITADEL ADVISORS LLC
$188.9KNew
BROWN BROTHERS HARRIMAN & CO
$172.9K0.0%
HighTower Advisors, LLC
$143.7K0.0%
RVW Wealth, LLC
$131.4K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$125.1K0.0%
LEUCADIA NATIONAL CORP
$119.0KNew
Miracle Mile Advisors, LLC
$116.8K0.0%
McCarthy Asset Management, Inc.
$109.6K--
BANK OF AMERICA CORP /DE/
$103.1K0.0%
VANGUARD FIDUCIARY TRUST CO
$91.1K0.0%
MORGAN STANLEY
$82.8K+13.5%
LPL Financial LLC
$75.2K-22.6%
Cannon Financial Strategists, Inc.
$73.0KNew
UBS Group AG
$16.5K+465.8%
See all 29 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TTRX

Earnings Per Share

13fpro.ai/company/TTRX

Loading ratio trend…

TTRX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Turn Therapeutics Inc. (TTRX): stock profile, AI score and financials

Turn Therapeutics Inc. (TTRX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TTRX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of TTRX by reported 13-F value include SteelPeak Wealth, IEQ CAPITAL, DDFG, based on the most recent SEC filings. TTRX trades on the Nasdaq exchange and files with the SEC under CIK 2023016. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TTRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Turn Therapeutics Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 2023016 →